SCYX FY 2022 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$38M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$5M-61.3% YoY

Gross Profit

$4M87.7% margin

Operating Income

-$86M-1684.5% margin

Net Income

-$63M-1233.7% margin

EPS (Diluted)

$-1.47

Cash Flow

Operating Cash Flow

-$80M

Free Cash Flow

-$80M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$88M

Total Liabilities

$85M

Stockholders' Equity

$3M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$13M	-61.3%
Gross Profit	$4M	$13M	-65.3%
Operating Income	-$86M	-$61M	-41.0%
Net Income	-$63M	-$33M	-91.1%